Published in Eur J Clin Microbiol Infect Dis on March 10, 2004
Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant (2011) 1.84
Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol (2010) 1.74
Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin Vaccine Immunol (2007) 1.70
Nanobacteria are mineralo fetuin complexes. PLoS Pathog (2008) 1.42
Molecular identification of bacteria from aseptically loose implants. Clin Orthop Relat Res (2008) 1.37
Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant (2011) 1.31
Control of carry-over contamination for PCR-based DNA methylation quantification using bisulfite treated DNA. Nucleic Acids Res (2006) 1.17
Automatic identification of species-specific repetitive DNA sequences and their utilization for detecting microbial organisms. Bioinformatics (2009) 1.15
Eight-plex PCR and liquid-array detection of bacterial and viral pathogens in cerebrospinal fluid from patients with suspected meningitis. J Clin Microbiol (2009) 1.10
Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans. J Clin Microbiol (2007) 1.07
Generation of non-genomic oligonucleotide tag sequences for RNA template-specific PCR. BMC Biotechnol (2006) 1.00
Microbial invasion of the amniotic cavity in pregnancies with small-for-gestational-age fetuses. J Perinat Med (2010) 0.95
Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods. J Perinat Med (2010) 0.92
A new method to extract dental pulp DNA: application to universal detection of bacteria. PLoS One (2007) 0.90
Tentacle probes: eliminating false positives without sacrificing sensitivity. Nucleic Acids Res (2007) 0.86
Molecular identification of novel intermediate host species of Angiostrongylus vasorum in Greater London. Parasitol Res (2014) 0.84
Webtag: a new web tool providing tags/anchors for RT-PCR experiments with prokaryotes. BMC Biotechnol (2007) 0.83
Quantitative assessment of the effect of uracil-DNA glycosylase on amplicon DNA degradation and RNA amplification in reverse transcription-PCR. Virol J (2005) 0.81
A new method to prevent carry-over contaminations in two-step PCR NGS library preparations. Nucleic Acids Res (2015) 0.80
Detection of bacteria with molecular methods in prosthetic joint infection: sonication fluid better than periprosthetic tissue. Acta Orthop (2016) 0.80
How to deal with PCR contamination in molecular microbial ecology. Microb Ecol (2014) 0.79
Widespread occurrence of bacterial human virulence determinants in soil and freshwater environments. Appl Environ Microbiol (2013) 0.78
Development of a versatile TaqMan™ real-time quantitative PCR (RT-qPCR) compliant anchor sequence to quantify bacterial gene transcripts from RNA samples containing carryover genomic DNA. BMC Biotechnol (2013) 0.75
First experience of a multicenter external quality assessment of molecular 16S rRNA gene detection in bone and joint infections. J Clin Microbiol (2014) 0.75
Radical gas-based DNA decontamination for ultra-sensitive molecular experiments. Microbes Environ (2012) 0.75
Case report of Salmonella cross-contamination in a food laboratory. BMC Res Notes (2016) 0.75
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
Avoiding false positives with PCR. Nature (1989) 30.66
Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene (1990) 10.41
Shedding light on PCR contamination. Nature (1990) 6.49
Nucleic acid sequence-based amplification. Nature (1991) 5.66
Strand displacement amplification--an isothermal, in vitro DNA amplification technique. Nucleic Acids Res (1992) 4.47
Contamination and sensitivity issues with a real-time universal 16S rRNA PCR. J Clin Microbiol (2000) 4.44
Purification of Thermus aquaticus DNA polymerase expressed in Escherichia coli. Anal Biochem (1990) 3.92
Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format. Proc Natl Acad Sci U S A (1989) 3.56
Elimination of contaminating DNA within polymerase chain reaction reagents: implications for a general approach to detection of uncultured pathogens. J Clin Microbiol (1993) 3.22
Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet (1993) 3.20
Polymerase chain reaction: trenches to benches. J Clin Microbiol (1991) 2.99
Preventing false positives: quantitative evaluation of three protocols for inactivation of polymerase chain reaction amplification products. J Clin Microbiol (1993) 2.63
Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol (1996) 2.44
Taq polymerase contains bacterial DNA of unknown origin. Mol Cell Probes (1990) 2.41
Post-PCR sterilization: a method to control carryover contamination for the polymerase chain reaction. Nucleic Acids Res (1991) 2.38
Detection of DNA contamination in Taq polymerase. Biotechniques (1991) 2.32
Frequent contamination of Taq polymerase with DNA. Clin Chem (1990) 2.23
False-positive results and the polymerase chain reaction. Lancet (1988) 2.22
Improving PCR efficiency. Nature (1990) 2.19
The ligation amplification reaction (LAR)--amplification of specific DNA sequences using sequential rounds of template-dependent ligation. Genomics (1989) 2.19
Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol (1995) 2.16
Extensive evaluation of a seronegative participant in an HIV-1 vaccine trial as a result of false-positive PCR. Lancet (1997) 2.13
Risk assessment models and contamination management: implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology. J Clin Microbiol (2002) 2.08
Systemic candidiasis in cancer patients. Am J Med (1984) 2.05
Avoidance of PCR false positives [corrected]. Nature (1990) 2.00
Identification and elimination of DNA sequences in Taq DNA polymerase. J Clin Microbiol (1994) 1.99
PCR: how to kill unwanted DNA. Biotechniques (1992) 1.96
Use of UV irradiation to reduce false positivity in polymerase chain reaction. Biotechniques (1991) 1.93
Contaminations occurring in fungal PCR assays. J Clin Microbiol (1999) 1.86
Effect of nucleotide analogs on the cleavage of DNA by the restriction enzymes AluI, DdeI, HinfI, RsaI, and TaqI. J Biol Chem (1983) 1.78
Elimination of bacterial DNA from Taq DNA polymerases by restriction endonuclease digestion. J Clin Microbiol (1999) 1.63
Laboratory experience and guidelines for avoiding false positive polymerase chain reaction results. Eur J Clin Chem Clin Biochem (1993) 1.62
Post-PCR sterilization: development and application to an HIV-1 diagnostic assay. Nucleic Acids Res (1991) 1.57
Utilizing uracil DNA glycosylase to control carryover contamination in PCR: characterization of residual UDG activity following thermal cycling. Biotechniques (1992) 1.48
Termination sites of the in vitro nick-translation reaction on DNA that had photoreacted with psoralen. Proc Natl Acad Sci U S A (1983) 1.46
More light on PCR contamination. Nature (1990) 1.45
Source of contamination in polymerase chain reaction assay. Lancet (1990) 1.42
Rapid identification of bacteria by PCR-single-strand conformation polymorphism. J Clin Microbiol (1994) 1.41
The effects of covalent additions of a psoralen on transcription by E. coli RNA polymerase. Nucleic Acids Res (1987) 1.39
A novel method employing UNG to avoid carry-over contamination in RNA-PCR. Nucleic Acids Res (1993) 1.36
More false-positive problems. Nature (1990) 1.32
Qiagen DNA extraction kits for sample preparation for legionella PCR are not suitable for diagnostic purposes. J Clin Microbiol (2002) 1.31
A past mutation at isoleucine 397 is now a common cause of moderate/mild haemophilia B. Br J Haematol (1990) 1.29
Quantitation of cyclobutane pyrimidine dimer formation in double- and single-stranded DNA fragments of defined sequence. Radiat Res (1982) 1.27
Characterization of contaminating DNA in Taq polymerase which occurs during amplification with a primer set for Legionella 5S ribosomal RNA. Mol Cell Probes (1994) 1.26
Single-step purification of a thermostable DNA polymerase expressed in Escherichia coli. Biotechniques (1995) 1.22
Eliminating PCR contamination: is UV irradiation the answer? J Virol Methods (1991) 1.22
Use of psoralen as extinguisher of contaminated DNA in PCR. Nucleic Acids Res (1990) 1.21
Use of PCR primers containing a 3'-terminal ribose residue to prevent cross-contamination of amplified sequences. Nucleic Acids Res (1993) 1.21
Removal of DNA contamination in polymerase chain reaction reagents by ultraviolet irradiation. Methods Enzymol (1993) 1.16
Reliability of PCR decontamination systems. PCR Methods Appl (1994) 1.16
Death from inappropriate therapy for Lyme disease. Clin Infect Dis (2000) 1.15
Dealing with contamination: enzymatic control of carryover contamination in PCR. PCR Methods Appl (1993) 1.15
Use of modified nucleotides and uracil-DNA glycosylase (UNG) for the control of contamination in the PCR-based amplification of RNA. Mol Cell Probes (1992) 1.15
Parameters affecting susceptibility of PCR contamination to UV inactivation. Biotechniques (1991) 1.10
Identification of contaminating fungal DNA sequences in Zymolyase. J Clin Microbiol (1999) 1.10
Polymerase chain reaction decontamination: the wipe test. Lancet (1990) 1.09
Use of gamma irradiation to eliminate DNA contamination for PCR. Nucleic Acids Res (1990) 1.09
Environmental contamination leading to false-positive polymerase chain reaction for pertussis. Pediatr Infect Dis J (1994) 1.06
DNase I treatment of Taq DNA polymerase for complete PCR decontamination. Biotechniques (1992) 1.06
Decontaminating the polymerase chain reaction. Biotechniques (1991) 1.04
False-positive results of PCR testing for Lyme disease. Clin Infect Dis (2001) 1.01
Removal of contaminating DNA from PCR reagents by ultrafiltration. Biotechniques (1994) 0.98
Protocol for ultraviolet irradiation of surfaces to reduce PCR contamination. PCR Methods Appl (1993) 0.97
Amplification of residual DNA sequences in sterile bronchoscopes leading to false-positive PCR results. J Clin Microbiol (1996) 0.95
Detection of Candida spp. in blood cultures using nucleic acid sequence-based amplification (NASBA). Diagn Microbiol Infect Dis (2001) 0.94
Branched DNA signal amplification. Biotechnology (N Y) (1994) 0.93
Sites of termination of in vitro DNA synthesis on psoralen phototreated single-stranded templates. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 0.91
A systematic and quantitative analysis of PCR template contamination. J Forensic Sci (2000) 0.90
Evidence of contamination in PCR laboratory disposables. Naturwissenschaften (1995) 0.86
GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum. J Clin Microbiol (1997) 0.86
False-positive polymerase chain reaction results in the diagnosis of herpes simplex encephalitis. J Infect Dis (1995) 0.85
False-positive polymerase chain reaction results for human papillomavirus in lichen planus. Potential laboratory pitfalls of this procedure. J Am Acad Dermatol (1996) 0.84
Failure of ultra-violet irradiation and autoclaving to eliminate PCR contamination. Mol Cell Probes (1992) 0.84
Application of hydroxylamine hydrochloride for post-PCR sterilization. Mol Cell Probes (1993) 0.80
UV and clean air result in contamination-free PCR. Leukemia (1999) 0.79
Elimination of PCR carryover. Am Biotechnol Lab (1992) 0.77
False-positive diagnosis of tuberculosis with PCR. Lancet (1996) 0.77
UV irradiation of polystyrene pipets releases PCR inhibitors. Biotechniques (1998) 0.76
The false-positive polymerase chain reaction and the ostrich. J Infect Dis (1995) 0.75
Evacuated tubes and possible false-positive PCR results with blood samples. S Afr Med J (1995) 0.75
Nucleic acid removal from Taq polymerase preparations using an aqueous/organic biphasic system. Biotechniques (1999) 0.75
A statistical method for the detection of false positives and false negatives in microtitre format PCR assays. J Virol Methods (1992) 0.75
Primers determine the sensitivity of PCR-mediated hepatitis B virus DNA detection and pretreatment of PCR mixture with 8-methoxypsoralen eliminates false-positive results. Mol Cells (1997) 0.75
Exclusion of false-positive PCR viral diagnosis by single-strand conformation polymorphism. Lancet (1992) 0.75
Quality control for DNA contamination in laboratories using PCR-based class II HLA typing methods. Hum Immunol (1997) 0.75
The magnetic immuno polymerase chain reaction assay for direct detection of salmonellae in fecal samples. J Clin Microbiol (1992) 3.56
Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area. J Antimicrob Chemother (1999) 3.42
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother (1998) 3.21
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). Diagn Microbiol Infect Dis (1999) 3.11
Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect (2011) 2.83
Comparison of genotypic and phenotypic methods for species-level identification of clinical isolates of coagulase-negative staphylococci. J Clin Microbiol (2005) 2.56
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis (2001) 2.39
Transmission of methicillin-resistant Staphylococcus aureus strains between different kinds of pig farms. Vet Microbiol (2007) 2.16
In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]. Lancet (2001) 2.14
Methicillin-resistant staphylococci isolated from animals. Vet Microbiol (2004) 2.01
Evaluation of the magnetic immuno PCR assay for rapid detection of Salmonella. Eur J Clin Microbiol Infect Dis (1991) 1.85
Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates. Antimicrob Agents Chemother (2003) 1.76
Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe. Antimicrob Agents Chemother (1999) 1.75
The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother (1998) 1.71
Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group. J Antimicrob Chemother (1999) 1.69
Rapid detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother (2010) 1.68
The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J Antimicrob Chemother (1999) 1.68
[Fatal pneumonia in an adolescent due to community-acquired methicillin-resistant Staphylococcus aureus positive for Panton-Valentine-leukocidin]. Ned Tijdschr Geneeskd (2003) 1.68
Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. J Antimicrob Chemother (2001) 1.59
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS Immunol Med Microbiol (1999) 1.51
Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2001) 1.48
Cloning and characterization of an accessory gene regulator (agr)-like locus from Staphylococcus epidermidis. FEMS Microbiol Lett (1998) 1.48
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (1998) 1.48
Presence of integron-associated resistance in the community is widespread and contributes to multidrug resistance in the hospital. J Clin Microbiol (2002) 1.46
Short term micro-evolution and PCR-detection of methicillin-resistant and -susceptible Staphylococcus aureus sequence type 398. Eur J Clin Microbiol Infect Dis (2009) 1.42
Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe. Eur J Clin Microbiol Infect Dis (2000) 1.42
Rapid identification of bacteria by PCR-single-strand conformation polymorphism. J Clin Microbiol (1994) 1.41
Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother (2000) 1.40
Molecular identification of bacteria by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene. J Clin Microbiol (1995) 1.38
Novel mobile variants of staphylococcal cassette chromosome mec in Staphylococcus aureus. Antimicrob Agents Chemother (2006) 1.35
A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases. Int J Antimicrob Agents (2011) 1.34
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. J Clin Microbiol (2000) 1.32
Novel gene cassettes and integrons. Antimicrob Agents Chemother (2001) 1.31
mecA gene is widely disseminated in Staphylococcus aureus population. J Clin Microbiol (2002) 1.30
Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. J Clin Microbiol (2003) 1.29
Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit. J Hosp Infect (2002) 1.29
Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects. Clin Microbiol Infect (2010) 1.25
Methicillin-resistant Staphylococcus aureus in horses and horse personnel: an investigation of several outbreaks. Vet Microbiol (2009) 1.25
Cloning and occurrence of czrC, a gene conferring cadmium and zinc resistance in methicillin-resistant Staphylococcus aureus CC398 isolates. Antimicrob Agents Chemother (2010) 1.24
Increased prevalence of class I integrons in Escherichia coli, Klebsiella species, and Enterobacter species isolates over a 7-year period in a German university hospital. J Clin Microbiol (2001) 1.23
In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates. Antimicrob Agents Chemother (2000) 1.23
Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents (2003) 1.22
Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates. J Antimicrob Chemother (2001) 1.22
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents (2004) 1.20
Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay. J Clin Microbiol (1994) 1.19
Comparison of the identification of coagulase-negative staphylococci by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tuf sequencing. Eur J Clin Microbiol Infect Dis (2011) 1.18
Fluoroquinolones: structure and target sites. Curr Drug Targets (2003) 1.17
Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals. M.A.R.S. Study Group. Multicentre Study on Antibiotic Resistance in Staphylococci. Eur J Clin Microbiol Infect Dis (2000) 1.15
Sustained low prevalence of meticillin-resistant Staphylococcus aureus upon admission to hospital in The Netherlands. J Hosp Infect (2011) 1.15
A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin. Clin Microbiol Infect (2013) 1.13
Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolates from 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds. SENTRY Participants Group. Eur J Clin Microbiol Infect Dis (1999) 1.12
Monoclonal antibodies that react with live Listeria spp. Appl Environ Microbiol (1993) 1.12
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother (2000) 1.09
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Antimicrob Agents Chemother (2001) 1.08
Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme. Eur J Clin Microbiol Infect Dis (1999) 1.07
Transmission of methicillin-resistant Staphylococcus intermedius between humans and animals. Vet Microbiol (2007) 1.06
Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Eur J Clin Microbiol Infect Dis (2002) 1.03
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins. Antimicrob Agents Chemother (1999) 1.02
An algorithm to estimate the importance of bacterial acquisition routes in hospital settings. Am J Epidemiol (2007) 1.01
Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011. Euro Surveill (2014) 1.00
Monoclonal antibodies that detect live salmonellae. Appl Environ Microbiol (1992) 1.00
Comparison of typing methods for Clostridium difficile isolates. J Clin Microbiol (1993) 1.00
Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group. Eur J Clin Microbiol Infect Dis (1999) 0.99
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998. Microb Drug Resist (2000) 0.99
Detection of Candida spp. in blood cultures using nucleic acid sequence-based amplification (NASBA). Diagn Microbiol Infect Dis (2001) 0.94
Control of nosocomial multiresistant Enterobacteriaceae using a temporary restrictive antibiotic agent policy. Eur J Clin Microbiol Infect Dis (2001) 0.93
Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species. J Microbiol Methods (1999) 0.93
Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation. J Virol (1988) 0.92
Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates. Int J Antimicrob Agents (2001) 0.92
Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1995) 0.92
Phagocytosis of herpes simplex virus by human granulocytes and monocytes. Arch Virol (1989) 0.90
Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis. Vet Microbiol (2008) 0.90
[Methicillin resistant Staphylococcus aureus (MRSA) infection in a dog in the Netherlands]. Tijdschr Diergeneeskd (2003) 0.88
Detection of Salmonella species in fecal samples by immunomagnetic separation and PCR. J Clin Microbiol (1995) 0.88
Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates. J Antimicrob Chemother (2001) 0.88
The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial. Int J Antimicrob Agents (2004) 0.88
Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes. J Gen Virol (1990) 0.88
Colonization with multiple Staphylococcus aureus strains among patients in European intensive care units. Infect Control Hosp Epidemiol (2009) 0.87
Effect of SSB protein on cleavage of single-stranded DNA by phi X gene A protein and A* protein. Nucleic Acids Res (1986) 0.87
Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe. Drug Resist Updat (2006) 0.87
Molecular analyses of possible mechanisms coding for low-level mupirocin resistance in clinical Staphylococcus aureus isolates. Eur J Clin Microbiol Infect Dis (2000) 0.86
Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children. Gut (1994) 0.86
Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains. J Antimicrob Chemother (1998) 0.86
Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis (2006) 0.86
Comparison of immunomagnetic beads coated with protein A, protein G, or goat anti-mouse immunoglobulins. Applications in enzyme immunoassays and immunomagnetic separations. J Immunol Methods (1993) 0.85
Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals. SENTRY Participants Group. Eur J Clin Microbiol Infect Dis (1999) 0.84
Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis (2002) 0.83
Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa. J Antimicrob Chemother (2002) 0.83
Hair follicles as a niche of Staphylococcus aureus in the nose; is a more effective decolonisation strategy needed? J Hosp Infect (2010) 0.83
Evaluation of a commercial microarray as a confirmation test for the presence of extended-spectrum β-lactamases in isolates from the routine clinical setting. Clin Microbiol Infect (2011) 0.83
Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics. J Antimicrob Chemother (2000) 0.83
Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group. Int J Antimicrob Agents (1999) 0.82
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones. Antimicrob Agents Chemother (1999) 0.82
Structural alterations in the translational attenuator of constitutively expressed erm(A) genes in Staphylococcus aureus. Antimicrob Agents Chemother (2001) 0.82
Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis (2001) 0.81
In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis. J Antimicrob Chemother (2002) 0.81